The Alaska Vaccine Allocation Advisory Committee (AVAAC) is meeting at 4 p.m. on Monday, Jan. 11 to take public testimony on Phase 1c. This is a chance to have your opinions heard on the next group to become eligible for COVID-19 vaccine after Alaskans in Phases 1a and 1b have adequate opportunity to get vaccinated (looking ahead weeks or months from now).
We encourage and look forward to hearing public comments.
CDC’s Advisory Committee on Immunization Practices (ACIP) has recommended that Phase 1c include persons aged 65–74 years, persons aged 16–64 years with high-risk medical conditions, and other essential workers. Because Alaska has already included Alaskans 65 years of age and most essential workers in Phase 1b, AVAAC and DHSS are proposing that Phase 1c include persons aged 16-49 years of age with high-risk medical conditions as well as any additional essential workers.
How to view the AVAAC Public Comment Meetings:This meeting will be held via Zoom Webinar, Facebook Live via the DHSS Facebook page, and by telephone. • Access via Zoom: alaska.zoom.us/webinar/register/WN_6auQiUk7TQ2Hf_XBQz2XQQ• Dial-in access will be available:US +1-253-215-8782 Webinar ID: 864 7890 1614• Access via Facebook will be available via the DHSS page: https://www.facebook.com/alaska.dhss/
How to provide public comments: The University of Alaska Anchorage Center for Human Development is accepting public comments on behalf of the Alaska Department of Health and Social and Services in the following ways:• Submit written comments: form.jotform.com/203526539420149
These comments will be given to the DHSS Vaccine Task Force and Alaska COVID-19 Vaccine Allocation Advisory Committee and comments may be made public with personal identifiers removed. Participants are encouraged to remove personal identifiers to protect their privacy. Comments will not be read live during the session.• Sign up on the list to provide live comments: alaska.zoom.us/webinar/register/WN_6auQiUk7TQ2Hf_XBQz2XQQ
Live comments will be limited to 1 min (60 seconds). A limited number of individuals will be able to comment during this meeting. Once you sign up, you will be provided a confirmation of your time slot via email or phone. Please note that we are asking that comments be focused on Phase 1c.